Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency
Hanny Al‐Samkari(Harvard University), Rachael F. Grace(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Sujit Sheth(Columbia University Irving Medical Center), D. Holmes Morton(Clinic for Special Children), Stefan Eber(Clinic for Special Children), Satheesh Chonat(Emory University), Kevin H.M. Kuo(University Health Network), Vicky R. Breakey(McMaster University), Nina Kollmar(Klinikum Kassel), P FORBES(Boston Children's Hospital), Robert J. Klaassen(Children's Hospital of Eastern Ontario), Eduard J. van Beers(Utrecht University), Heng Wang(Zhejiang Provincial People's Hospital), Mukta Sharma(Children's Mercy Hospital)
Cited by 22
Related Papers
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
|Blood|2018|165
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
|New England Journal of Medicine|2019|162